Mills Manipulation and Mulligan PRP Affect Pain, Grip Strength and Function on Lateral Epicondylitis
- Conditions
- Lateral Epicondylitis
- Interventions
- Other: Baseline Treatment along with Mill's manipulation and Mulligan's pain relief phenomenaOther: Baseline Treatment along with Mill's manipulation
- Registration Number
- NCT06087081
- Lead Sponsor
- Riphah International University
- Brief Summary
The aim of this study is to find the comparative effects of mills manipulation with or without Mulligan pain release phenomena on the pain, grip strength, and function in patients with Lateral Epicondylitis. The results of this study will provide clinicians with valuable insights into the most effective treatment approach for lateral epicondylitis, enabling them to stay up-to-date with the latest practice methods and optimize patient care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 38
- Subjects diagnosed with lateral epicondylitis with positive Cozen test
- NPRS >3
- Both male and female patients
- Sub-acute lateral epicondylitis >4weeks-<3 months
- Subjects with age range 20-40 year
- Acute lateral epicondylitis
- Subjects with elbow and around elbow fracture
- Subjects with ligament injury around elbow joint
- Any neurological conditions
- Any open wounds around the area of elbow
- Hyper-sensitive skin, skin allergies, diagnosed subjects with malignancy, diagnosed subjects skin diseases, diagnosed subjects with systemic illness
- Traumatic injury to the elbow joint
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group B Baseline Treatment along with Mill's manipulation and Mulligan's pain relief phenomena Baseline Treatment along with Mill's manipulation and Mulligan's pain relief phenomena Group A Baseline Treatment along with Mill's manipulation Baseline treatment along with Mill's manipulation
- Primary Outcome Measures
Name Time Method Numeric Pain Rate Scale 4th Week The NPRS for pain is a unidirectional measure of pain intensity in adults similar to the pain Visual Analogue Scale(VAS), the NPRS is anchored by terms describing pain severity extremes. The common format is a horizontal bar or line with 11-items (0-10). 0 on NPRS indicates no pain, 5 indicates moderate pain and 10 indicates worst possible pain. NPRS is easy to administer and takes less than 1minute. The NPRS can be administered verbally (on telephone) or graphically for self- completion. Reliability: high test-retest reliability (r=0.96). Validity: (0.86-0.95).
Patient-Rated Tennis Elbow Evaluation 4th Week Functional Disability was measured by PRTEE, a 15-item questionnaire designed to measure forearm pain and disability in patients with Lateral Epicondylitis. Patients have to rate their levels of tennis elbow pain and disability from 0 to 10 and consists of 2 sub-scales. There is a pain sub-scale with 5 items (0 = no pain, 50 = worst pain) and Functional sub-scale consists of Specific activities with 6 items (0 = no hinder, 60 =unable to do) and Usual activities with 4 items (0 = no difficulty, 10 = unable to do). The PRTEE was found to be a reliable, reproducible and sensitive instrument for the assessment of pain and disability in chronic lateral epicondylitis subjects (Cronbach's alpha is 0.98).
Hand Held Dynamometer 4th Week The maximal grip strength of the affected arm was assessed using a grip-strength dynamometer. Patients were asked to grip the dynamometer as hard as possible 3 times at 10 s rest interval. Grip force should be applied smoothly without rapid jerking motion. Patient must be seated with 90 degrees of elbow flexion, shoulder adduction, slight extension in the wrist, and the forearm in the neutral position. The highest grip-strength number was registered. Reliability: high test-retest reliability(r=0.9864)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Ittefaq Hospital Trust
🇵🇰Lahore, Punjab, Pakistan